Back to top of page

Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)

List of required information for application:

1. Project title: A concise but descriptive title for the proposed research project.

2. Abstract: A brief summary of the proposed research, including the objectives, methods, and expected outcomes.

3. Project description: A detailed description of the proposed research project, including the rationale, research plan, methodology, and timeline.

4. Significance and impact: An explanation of the potential significance and impact of the proposed research on the field of neurotherapeutics and clinical practice.

5. Background and literature review: A review of relevant literature and previous research in the field of biomarkers and biomarker signatures for neurological and neuromuscular disorders.

6. Research plan: A comprehensive plan outlining the specific aims, research questions/hypotheses, experimental design, data analysis, and interpretation.

7. Preliminary data: A presentation of any preliminary data or pilot studies that support the feasibility and relevance of the proposed research.

8. Human subjects: A description of the human subjects involved in the research, including the recruitment strategy, informed consent process, and measures to protect participants' rights and privacy.

9. Animal studies: If applicable, a justification and description of the animal studies involved in the research, including the species, number of animals, and ethical considerations.

10. Standardized human samples or datasets: A plan for obtaining and utilizing carefully standardized human samples or datasets for the preliminary human evaluation.

11. Team qualifications: An overview of the qualifications and expertise of the research team, including the principal investigator and key personnel.

12. Budget: A detailed budget plan outlining the projected expenses for the proposed research, including personnel salaries, equipment, supplies, and any other costs.

13. Timeline: A clear timeline outlining the specific milestones and activities of the proposed research project.

14. Evaluation and validation plan: A plan for evaluating and validating the candidate biomarkers or biomarker signatures, including the analytical and clinical validation studies.

15. References: A list of references cited throughout the application.

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows